Patent for Enhancing Immunotherapy in Cancer Treatment Granted

This patent provides intellectual property protection for the ongoing human trial that evaluates the effect of the combination of GR-MD-02 with approved cancer immunotherapy drugs08/15/2017
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news